Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy In Heart Failure Study

Results of a preclinical study involving the injection of myoblasts modified to express stromal derived factor-1(alpha) protein (SDF-1) into the scar tissue of the myocardium of rats, which suggest improved heart function, were recently presented at two scientific meetings — the International Society for Magnetic Resonance in Medicine (ISMRM) in Toronto, and the American Society of Gene Therapy Meeting (ASGT) in Boston.

More: continued here

Filed under: Cardiovascular on July 26th, 2008